Literature DB >> 15531764

Structure and reactivity of human mitochondrial 2,4-dienoyl-CoA reductase: enzyme-ligand interactions in a distinctive short-chain reductase active site.

Magnus S Alphey1, Wenhua Yu, Emma Byres, Ding Li, William N Hunter.   

Abstract

Fatty acid catabolism by beta-oxidation mainly occurs in mitochondria and to a lesser degree in peroxisomes. Poly-unsaturated fatty acids are problematic for beta-oxidation, because the enzymes directly involved are unable to process all the different double bond conformations and combinations that occur naturally. In mammals, three accessory proteins circumvent this problem by catalyzing specific isomerization and reduction reactions. Central to this process is the NADPH-dependent 2,4-dienoyl-CoA reductase. We present high resolution crystal structures of human mitochondrial 2,4-dienoyl-CoA reductase in binary complex with cofactor, and the ternary complex with NADP(+) and substrate trans-2,trans-4-dienoyl-CoA at 2.1 and 1.75 A resolution, respectively. The enzyme, a homotetramer, is a short-chain dehydrogenase/reductase with a distinctive catalytic center. Close structural similarity between the binary and ternary complexes suggests an absence of large conformational changes during binding and processing of substrate. The site of catalysis is relatively open and placed beside a flexible loop thereby allowing the enzyme to accommodate and process a wide range of fatty acids. Seven single mutants were constructed, by site-directed mutagenesis, to investigate the function of selected residues in the active site thought likely to either contribute to the architecture of the active site or to catalysis. The mutant proteins were overexpressed, purified to homogeneity, and then characterized. The structural and kinetic data are consistent and support a mechanism that derives one reducing equivalent from the cofactor, and one from solvent. Key to the acquisition of a solvent-derived proton is the orientation of substrate and stabilization of a dienolate intermediate by Tyr-199, Asn-148, and the oxidized nicotinamide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531764     DOI: 10.1074/jbc.M411069200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Nonprocessive [2 + 2]e- off-loading reductase domains from mycobacterial nonribosomal peptide synthetases.

Authors:  Arush Chhabra; Asfarul S Haque; Ravi Kant Pal; Aneesh Goyal; Rajkishore Rai; Seema Joshi; Santosh Panjikar; Santosh Pasha; Rajan Sankaranarayanan; Rajesh S Gokhale
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

2.  Studies of human 2,4-dienoyl CoA reductase shed new light on peroxisomal β-oxidation of unsaturated fatty acids.

Authors:  Tian Hua; Dong Wu; Wei Ding; Jiangyun Wang; Neil Shaw; Zhi-Jie Liu
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

3.  Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis.

Authors:  Guanghua Rong; Renqian Zhong; Ana Lleo; Patrick S C Leung; Christopher L Bowlus; Guo-Xiang Yang; Chen-Yen Yang; Ross L Coppel; Aftab A Ansari; Dean A Cuebas; Howard J Worman; Pietro Invernizzi; Gregory J Gores; Gary Norman; Xiao-Song He; M Eric Gershwin
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

4.  In silico structural characterization of protein targets for drug development against Trypanosoma cruzi.

Authors:  Carlyle Ribeiro Lima; Nicolas Carels; Ana Carolina Ramos Guimaraes; Pierre Tufféry; Philippe Derreumaux
Journal:  J Mol Model       Date:  2016-09-24       Impact factor: 1.810

5.  Sphenostylisins A-K: bioactive modified isoflavonoid constituents of the root bark of Sphenostylis marginata ssp. erecta.

Authors:  Jie Li; Li Pan; Ye Deng; Ulyana Muñoz-Acuña; Chunhua Yuan; Hongshan Lai; Heebyung Chai; Tangai E Chagwedera; Norman R Farnsworth; Esperanza J Carcache de Blanco; Chenglong Li; Djaja D Soejarto; A Douglas Kinghorn
Journal:  J Org Chem       Date:  2013-10-03       Impact factor: 4.354

6.  Structure and catalytic mechanism of human steroid 5beta-reductase (AKR1D1).

Authors:  Luigi Di Costanzo; Jason E Drury; David W Christianson; Trevor M Penning
Journal:  Mol Cell Endocrinol       Date:  2008-09-19       Impact factor: 4.102

7.  Metabolic fate of docosahexaenoic acid (DHA; 22:6n-3) in human cells: direct retroconversion of DHA to eicosapentaenoic acid (20:5n-3) dominates over elongation to tetracosahexaenoic acid (24:6n-3).

Authors:  Hui Gyu Park; Peter Lawrence; Matthew G Engel; Kumar Kothapalli; James Thomas Brenna
Journal:  FEBS Lett       Date:  2016-09-02       Impact factor: 4.124

8.  Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.

Authors:  Josie Ursini-Siegel; Ashish B Rajput; Huiling Lu; Virginie Sanguin-Gendreau; Dongmei Zuo; Vasilios Papavasiliou; Cynthia Lavoie; Jason Turpin; Katherine Cianflone; David G Huntsman; William J Muller
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

9.  Aldo-keto reductases in which the conserved catalytic histidine is substituted.

Authors:  Luigi Di Costanzo; Trevor M Penning; David W Christianson
Journal:  Chem Biol Interact       Date:  2008-11-05       Impact factor: 5.192

Review 10.  Medium- and short-chain dehydrogenase/reductase gene and protein families : the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes.

Authors:  K L Kavanagh; H Jörnvall; B Persson; U Oppermann
Journal:  Cell Mol Life Sci       Date:  2008-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.